NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Earendil Labs

Earendil Labs

Private
Middletown, DelawareHealthcare & Life Scienceshttps://earendil.bio/

Last Round

Series B

Mar 20, 2026

Total Funding Raised

$861.8M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Earendil Labs is a biotechnology company that develops an AI-driven platform for biologics discovery and development to treat autoimmune diseases and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

ai drug discoveryprotein therapeuticsbiologics discoveryin silico drug designantibody engineeringgenerative biologycomputational biologybiotech platformdrug development pipelinedeep learningpharma R&Dmolecular designprecision medicinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Earendil Labs Comparables

Compare Earendil Labs with similar companies based on industry and business-model similarity.

Earendil Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BigHat Biosciences
87%
LabGenius Therapeutics
82%
Alphabet Inc.
81%

Earendil Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 20, 2026
Series AJun 22, 2022

Earendil Labs Investors

Notable investors and investment history

Earendil Labs investors
InvestorRounds
DST GlobalSeries B
Hillhouse InvestmentSeries A, Series B
DimensionSeries B
渶策资本Series B
5Y CapitalSeries A
Luminous VenturesSeries B
Dimensional Fund AdvisorsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    Partnered with Helixon Therapeutics to advance therapeutic programs using AI.

  • Mar 20, 2026

    $787M round led by Dimensional Fund Advisors and Sanofi.

Earendil Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Earendil Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Earendil Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiddletown, Delaware
Year Founded2021
Last FundingMar 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.